2018-2023 Global Oral Vaccines Consumption Market Report

Publisher Name :
Date: 12-Sep-2018
No. of pages: 164

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Oral Vaccines market for 2018-2023.

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

In the last several years, global market of oral vaccines developed rapidly, with an average growth rate of 6.31%. In 2017, global revenue of oral vaccines is nearly 2.01 billion USD; the actual consumption is about 2.2 billion doses.

The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine in 2017 is about 94%, and the proportion is in decreasing trend from 2012 to 2017.

Over the next five years, LPI(LP Information) projects that Oral Vaccines will register a 7.0% CAGR in terms of revenue, reach US$ 3010 million by 2023, from US$ 2010 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Rotavirus Vaccine

- Cholera Vaccine

- Oral Polio Vaccine

- Others

Segmentation by application:

- Public

- Private

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Merck

- GSK

- Sanofi

- Lanzhou Institute

- Serum Institute

- Valneva

- Shanghai United Cell

- Bibcol

- PaxVax

- Vabiotech

- Tiantan Biological

- EuBiologics

- Panacea Biotec Ltd

- Bio-Med

- Halfkin Bio-Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Oral Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Oral Vaccines market by identifying its various subsegments.

- Focuses on the key global Oral Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Oral Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Oral Vaccines submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Oral Vaccines Consumption Market Report

Table of Contents

2018-2023 Global Oral Vaccines Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Vaccines Consumption 2013-2023
2.1.2 Oral Vaccines Consumption CAGR by Region
2.2 Oral Vaccines Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.2.4 Others
2.3 Oral Vaccines Consumption by Type
2.3.1 Global Oral Vaccines Consumption Market Share by Type (2013-2018)
2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2013-2018)
2.3.3 Global Oral Vaccines Sale Price by Type (2013-2018)
2.4 Oral Vaccines Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Vaccines Consumption by Application
2.5.1 Global Oral Vaccines Consumption Market Share by Application (2013-2018)
2.5.2 Global Oral Vaccines Value and Market Share by Application (2013-2018)
2.5.3 Global Oral Vaccines Sale Price by Application (2013-2018)

3 Global Oral Vaccines by Players
3.1 Global Oral Vaccines Sales Market Share by Players
3.1.1 Global Oral Vaccines Sales by Players (2016-2018)
3.1.2 Global Oral Vaccines Sales Market Share by Players (2016-2018)
3.2 Global Oral Vaccines Revenue Market Share by Players
3.2.1 Global Oral Vaccines Revenue by Players (2016-2018)
3.2.2 Global Oral Vaccines Revenue Market Share by Players (2016-2018)
3.3 Global Oral Vaccines Sale Price by Players
3.4 Global Oral Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Oral Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Oral Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Oral Vaccines by Regions
4.1 Oral Vaccines by Regions
4.1.1 Global Oral Vaccines Consumption by Regions
4.1.2 Global Oral Vaccines Value by Regions
4.2 Americas Oral Vaccines Consumption Growth
4.3 APAC Oral Vaccines Consumption Growth
4.4 Europe Oral Vaccines Consumption Growth
4.5 Middle East & Africa Oral Vaccines Consumption Growth

5 Americas
5.1 Americas Oral Vaccines Consumption by Countries
5.1.1 Americas Oral Vaccines Consumption by Countries (2013-2018)
5.1.2 Americas Oral Vaccines Value by Countries (2013-2018)
5.2 Americas Oral Vaccines Consumption by Type
5.3 Americas Oral Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Oral Vaccines Consumption by Countries
6.1.1 APAC Oral Vaccines Consumption by Countries (2013-2018)
6.1.2 APAC Oral Vaccines Value by Countries (2013-2018)
6.2 APAC Oral Vaccines Consumption by Type
6.3 APAC Oral Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Oral Vaccines by Countries
7.1.1 Europe Oral Vaccines Consumption by Countries (2013-2018)
7.1.2 Europe Oral Vaccines Value by Countries (2013-2018)
7.2 Europe Oral Vaccines Consumption by Type
7.3 Europe Oral Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Oral Vaccines by Countries
8.1.1 Middle East & Africa Oral Vaccines Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Oral Vaccines Value by Countries (2013-2018)
8.2 Middle East & Africa Oral Vaccines Consumption by Type
8.3 Middle East & Africa Oral Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Oral Vaccines Distributors
10.3 Oral Vaccines Customer

11 Global Oral Vaccines Market Forecast
11.1 Global Oral Vaccines Consumption Forecast (2018-2023)
11.2 Global Oral Vaccines Forecast by Regions
11.2.1 Global Oral Vaccines Forecast by Regions (2018-2023)
11.2.2 Global Oral Vaccines Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oral Vaccines Forecast by Type
11.8 Global Oral Vaccines Forecast by Application

12 Key Players Analysis
12.1 Merck
12.1.1 Company Details
12.1.2 Oral Vaccines Product Offered
12.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Merck News
12.2 GSK
12.2.1 Company Details
12.2.2 Oral Vaccines Product Offered
12.2.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 GSK News
12.3 Sanofi
12.3.1 Company Details
12.3.2 Oral Vaccines Product Offered
12.3.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Sanofi News
12.4 Lanzhou Institute
12.4.1 Company Details
12.4.2 Oral Vaccines Product Offered
12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Lanzhou Institute News
12.5 Serum Institute
12.5.1 Company Details
12.5.2 Oral Vaccines Product Offered
12.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Serum Institute News
12.6 Valneva
12.6.1 Company Details
12.6.2 Oral Vaccines Product Offered
12.6.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Valneva News
12.7 Shanghai United Cell
12.7.1 Company Details
12.7.2 Oral Vaccines Product Offered
12.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Shanghai United Cell News
12.8 Bibcol
12.8.1 Company Details
12.8.2 Oral Vaccines Product Offered
12.8.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Bibcol News
12.9 PaxVax
12.9.1 Company Details
12.9.2 Oral Vaccines Product Offered
12.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 PaxVax News
12.10 Vabiotech
12.10.1 Company Details
12.10.2 Oral Vaccines Product Offered
12.10.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Vabiotech News
12.11 Tiantan Biological
12.12 EuBiologics
12.13 Panacea Biotec Ltd
12.14 Bio-Med
12.15 Halfkin Bio-Pharmaceuticals

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Oral Vaccines
Table Product Specifications of Oral Vaccines
Figure Oral Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global Oral Vaccines Consumption Growth Rate 2013-2023 (M Doses)
Figure Global Oral Vaccines Value Growth Rate 2013-2023 ($ Millions)
Table Oral Vaccines Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Rotavirus Vaccine
Table Major Players of Rotavirus Vaccine
Figure Product Picture of Cholera Vaccine
Table Major Players of Cholera Vaccine
Figure Product Picture of Oral Polio Vaccine
Table Major Players of Oral Polio Vaccine
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Oral Vaccines Consumption Market Share by Type (2013-2018)
Figure Global Oral Vaccines Consumption Market Share by Type (2013-2018)
Table Global Oral Vaccines Revenue by Type (2013-2018) ($ million)
Table Global Oral Vaccines Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Oral Vaccines Value Market Share by Type (2013-2018)
Table Global Oral Vaccines Sale Price by Type (2013-2018)
Figure Oral Vaccines Consumed in Public
Figure Global Oral Vaccines Market: Public (2013-2018) (M Doses)
Figure Global Oral Vaccines Market: Public (2013-2018) ($ Millions)
Figure Global Public YoY Growth ($ Millions)
Figure Oral Vaccines Consumed in Private
Figure Global Oral Vaccines Market: Private (2013-2018) (M Doses)
Figure Global Oral Vaccines Market: Private (2013-2018) ($ Millions)
Figure Global Private YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Oral Vaccines Consumption Market Share by Application (2013-2018)
Figure Global Oral Vaccines Consumption Market Share by Application (2013-2018)
Table Global Oral Vaccines Value by Application (2013-2018)
Table Global Oral Vaccines Value Market Share by Application (2013-2018)
Figure Global Oral Vaccines Value Market Share by Application (2013-2018)
Table Global Oral Vaccines Sale Price by Application (2013-2018)
Table Global Oral Vaccines Sales by Players (2016-2018) (M Doses)
Table Global Oral Vaccines Sales Market Share by Players (2016-2018)
Figure Global Oral Vaccines Sales Market Share by Players in 2016
Figure Global Oral Vaccines Sales Market Share by Players in 2017
Table Global Oral Vaccines Revenue by Players (2016-2018) ($ Millions)
Table Global Oral Vaccines Revenue Market Share by Players (2016-2018)
Figure Global Oral Vaccines Revenue Market Share by Players in 2016
Figure Global Oral Vaccines Revenue Market Share by Players in 2017
Table Global Oral Vaccines Sale Price by Players (2016-2018)
Figure Global Oral Vaccines Sale Price by Players in 2017
Table Global Oral Vaccines Manufacturing Base Distribution and Sales Area by Players
Table Players Oral Vaccines Products Offered
Table Oral Vaccines Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Oral Vaccines Consumption by Regions 2013-2018 (M Doses)
Table Global Oral Vaccines Consumption Market Share by Regions 2013-2018
Figure Global Oral Vaccines Consumption Market Share by Regions 2013-2018
Table Global Oral Vaccines Value by Regions 2013-2018 ($ Millions)
Table Global Oral Vaccines Value Market Share by Regions 2013-2018
Figure Global Oral Vaccines Value Market Share by Regions 2013-2018
Figure Americas Oral Vaccines Consumption 2013-2018 (M Doses)
Figure Americas Oral Vaccines Value 2013-2018 ($ Millions)
Figure APAC Oral Vaccines Consumption 2013-2018 (M Doses)
Figure APAC Oral Vaccines Value 2013-2018 ($ Millions)
Figure Europe Oral Vaccines Consumption 2013-2018 (M Doses)
Figure Europe Oral Vaccines Value 2013-2018 ($ Millions)
Figure Middle East & Africa Oral Vaccines Consumption 2013-2018 (M Doses)
Figure Middle East & Africa Oral Vaccines Value 2013-2018 ($ Millions)
Table Americas Oral Vaccines Consumption by Countries (2013-2018) (M Doses)
Table Americas Oral Vaccines Consumption Market Share by Countries (2013-2018)
Figure Americas Oral Vaccines Consumption Market Share by Countries in 2017
Table Americas Oral Vaccines Value by Countries (2013-2018) ($ Millions)
Table Americas Oral Vaccines Value Market Share by Countries (2013-2018)
Figure Americas Oral Vaccines Value Market Share by Countries in 2017
Table Americas Oral Vaccines Consumption by Type (2013-2018) (M Doses)
Table Americas Oral Vaccines Consumption Market Share by Type (2013-2018)
Figure Americas Oral Vaccines Consumption Market Share by Type in 2017
Table Americas Oral Vaccines Consumption by Application (2013-2018) (M Doses)
Table Americas Oral Vaccines Consumption Market Share by Application (2013-2018)
Figure Americas Oral Vaccines Consumption Market Share by Application in 2017
Figure United States Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure United States Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Canada Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Canada Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Mexico Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Mexico Oral Vaccines Value Growth 2013-2018 ($ Millions)
Table APAC Oral Vaccines Consumption by Countries (2013-2018) (M Doses)
Table APAC Oral Vaccines Consumption Market Share by Countries (2013-2018)
Figure APAC Oral Vaccines Consumption Market Share by Countries in 2017
Table APAC Oral Vaccines Value by Countries (2013-2018) ($ Millions)
Table APAC Oral Vaccines Value Market Share by Countries (2013-2018)
Figure APAC Oral Vaccines Value Market Share by Countries in 2017
Table APAC Oral Vaccines Consumption by Type (2013-2018) (M Doses)
Table APAC Oral Vaccines Consumption Market Share by Type (2013-2018)
Figure APAC Oral Vaccines Consumption Market Share by Type in 2017
Table APAC Oral Vaccines Consumption by Application (2013-2018) (M Doses)
Table APAC Oral Vaccines Consumption Market Share by Application (2013-2018)
Figure APAC Oral Vaccines Consumption Market Share by Application in 2017
Figure China Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure China Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Japan Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Japan Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Korea Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Korea Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Southeast Asia Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure India Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure India Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Australia Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Australia Oral Vaccines Value Growth 2013-2018 ($ Millions)
Table Europe Oral Vaccines Consumption by Countries (2013-2018) (M Doses)
Table Europe Oral Vaccines Consumption Market Share by Countries (2013-2018)
Figure Europe Oral Vaccines Consumption Market Share by Countries in 2017
Table Europe Oral Vaccines Value by Countries (2013-2018) ($ Millions)
Table Europe Oral Vaccines Value Market Share by Countries (2013-2018)
Figure Europe Oral Vaccines Value Market Share by Countries in 2017
Table Europe Oral Vaccines Consumption by Type (2013-2018) (M Doses)
Table Europe Oral Vaccines Consumption Market Share by Type (2013-2018)
Figure Europe Oral Vaccines Consumption Market Share by Type in 2017
Table Europe Oral Vaccines Consumption by Application (2013-2018) (M Doses)
Table Europe Oral Vaccines Consumption Market Share by Application (2013-2018)
Figure Europe Oral Vaccines Consumption Market Share by Application in 2017
Figure Germany Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Germany Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure France Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure France Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure UK Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure UK Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Italy Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Italy Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Russia Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Russia Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Spain Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Spain Oral Vaccines Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Oral Vaccines Consumption by Countries (2013-2018) (M Doses)
Table Middle East & Africa Oral Vaccines Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Oral Vaccines Consumption Market Share by Countries in 2017
Table Middle East & Africa Oral Vaccines Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Oral Vaccines Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Oral Vaccines Value Market Share by Countries in 2017
Table Middle East & Africa Oral Vaccines Consumption by Type (2013-2018) (M Doses)
Table Middle East & Africa Oral Vaccines Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Oral Vaccines Consumption Market Share by Type in 2017
Table Middle East & Africa Oral Vaccines Consumption by Application (2013-2018) (M Doses)
Table Middle East & Africa Oral Vaccines Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Oral Vaccines Consumption Market Share by Application in 2017
Figure Egypt Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Egypt Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure South Africa Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure South Africa Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Israel Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Israel Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure Turkey Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Turkey Oral Vaccines Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Oral Vaccines Consumption Growth 2013-2018 (M Doses)
Figure GCC Countries Oral Vaccines Value Growth 2013-2018 ($ Millions)
Table Oral Vaccines Distributors List
Table Oral Vaccines Customer List
Figure Global Oral Vaccines Consumption Growth Rate Forecast (2018-2023) (M Doses)
Figure Global Oral Vaccines Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Oral Vaccines Consumption Forecast by Countries (2018-2023) (M Doses)
Table Global Oral Vaccines Consumption Market Forecast by Regions
Table Global Oral Vaccines Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Oral Vaccines Value Market Share Forecast by Regions
Figure Americas Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Americas Oral Vaccines Value 2018-2023 ($ Millions)
Figure APAC Oral Vaccines Consumption 2018-2023 (M Doses)
Figure APAC Oral Vaccines Value 2018-2023 ($ Millions)
Figure Europe Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Europe Oral Vaccines Value 2018-2023 ($ Millions)
Figure Middle East & Africa Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Middle East & Africa Oral Vaccines Value 2018-2023 ($ Millions)
Figure United States Oral Vaccines Consumption 2018-2023 (M Doses)
Figure United States Oral Vaccines Value 2018-2023 ($ Millions)
Figure Canada Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Canada Oral Vaccines Value 2018-2023 ($ Millions)
Figure Mexico Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Mexico Oral Vaccines Value 2018-2023 ($ Millions)
Figure Brazil Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Brazil Oral Vaccines Value 2018-2023 ($ Millions)
Figure China Oral Vaccines Consumption 2018-2023 (M Doses)
Figure China Oral Vaccines Value 2018-2023 ($ Millions)
Figure Japan Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Japan Oral Vaccines Value 2018-2023 ($ Millions)
Figure Korea Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Korea Oral Vaccines Value 2018-2023 ($ Millions)
Figure Southeast Asia Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Southeast Asia Oral Vaccines Value 2018-2023 ($ Millions)
Figure India Oral Vaccines Consumption 2018-2023 (M Doses)
Figure India Oral Vaccines Value 2018-2023 ($ Millions)
Figure Australia Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Australia Oral Vaccines Value 2018-2023 ($ Millions)
Figure Germany Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Germany Oral Vaccines Value 2018-2023 ($ Millions)
Figure France Oral Vaccines Consumption 2018-2023 (M Doses)
Figure France Oral Vaccines Value 2018-2023 ($ Millions)
Figure UK Oral Vaccines Consumption 2018-2023 (M Doses)
Figure UK Oral Vaccines Value 2018-2023 ($ Millions)
Figure Italy Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Italy Oral Vaccines Value 2018-2023 ($ Millions)
Figure Russia Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Russia Oral Vaccines Value 2018-2023 ($ Millions)
Figure Spain Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Spain Oral Vaccines Value 2018-2023 ($ Millions)
Figure Egypt Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Egypt Oral Vaccines Value 2018-2023 ($ Millions)
Figure South Africa Oral Vaccines Consumption 2018-2023 (M Doses)
Figure South Africa Oral Vaccines Value 2018-2023 ($ Millions)
Figure Israel Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Israel Oral Vaccines Value 2018-2023 ($ Millions)
Figure Turkey Oral Vaccines Consumption 2018-2023 (M Doses)
Figure Turkey Oral Vaccines Value 2018-2023 ($ Millions)
Figure GCC Countries Oral Vaccines Consumption 2018-2023 (M Doses)
Figure GCC Countries Oral Vaccines Value 2018-2023 ($ Millions)
Table Global Oral Vaccines Consumption Forecast by Type (2018-2023) (M Doses)
Table Global Oral Vaccines Consumption Market Share Forecast by Type (2018-2023)
Table Global Oral Vaccines Value Forecast by Type (2018-2023) ($ Millions)
Table Global Oral Vaccines Value Market Share Forecast by Type (2018-2023)
Table Global Oral Vaccines Consumption Forecast by Application (2018-2023) (M Doses)
Table Global Oral Vaccines Consumption Market Share Forecast by Application (2018-2023)
Table Global Oral Vaccines Value Forecast by Application (2018-2023) ($ Millions)
Table Global Oral Vaccines Value Market Share Forecast by Application (2018-2023)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Oral Vaccines Market Share (2016-2018)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GSK Oral Vaccines Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Oral Vaccines Market Share (2016-2018)
Table Lanzhou Institute Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lanzhou Institute Oral Vaccines Market Share (2016-2018)
Table Serum Institute Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Serum Institute Oral Vaccines Market Share (2016-2018)
Table Valneva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valneva Oral Vaccines Market Share (2016-2018)
Table Shanghai United Cell Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shanghai United Cell Oral Vaccines Market Share (2016-2018)
Table Bibcol Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bibcol Oral Vaccines Market Share (2016-2018)
Table PaxVax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure PaxVax Oral Vaccines Market Share (2016-2018)
Table Vabiotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Vabiotech Oral Vaccines Market Share (2016-2018)
Table Tiantan Biological Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EuBiologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Panacea Biotec Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bio-Med Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Global Epinephrine Market Insights, Forecast to 2025
    Published: 15-Feb-2019        Price: US 4900 Onwards        Pages: 117
    Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.......
  • Global Atropine Market Insights, Forecast to 2025
    Published: 15-Feb-2019        Price: US 3900 Onwards        Pages: 116
    Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Atropine is ......
  • Quit Smoking Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 15-Feb-2019        Price: US 3000 Onwards        Pages: 141
    Quit Smoking Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Quit Smoking Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Quit Smoking Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Quit Smoking......
  • Global TNF Inhibitors Market Insights, Forecast to 2025
    Published: 15-Feb-2019        Price: US 3900 Onwards        Pages: 117
    The global TNF Inhibitors market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the TNF Inhibitors market based on company, product type, end user and key regions. This report studies the global market size of TNF Inhibitors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focu......
  • Procalcitonin (CAS 56645-65-9) Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 15-Feb-2019        Price: US 3000 Onwards        Pages: 136
    Procalcitonin Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Procalcitonin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Procalcitonin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Procalcitonin market cov......
  • Global Self-administered Drugs Market Insights, Forecast to 2025
    Published: 15-Feb-2019        Price: US 3900 Onwards        Pages: 117
    The global Self-administered Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Self-administered Drugs market based on company, product type, end user and key regions. This report studies the global market size of Self-administered Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and......
  • Global Prazosin Hydrochloride (CAS 19237-84-4) Market Insights, Forecast to 2025
    Published: 15-Feb-2019        Price: US 3900 Onwards        Pages: 117
    The global Prazosin Hydrochloride (CAS 19237-84-4) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Prazosin Hydrochloride (CAS 19237-84-4) market based on company, product type, end user and key regions. This report studies the global market size of Prazosin Hydrochloride (CAS 19237-84-4) in key regions like North America, E......
  • Global Solid Organ Transplant Immunosuppressant Market Growth 2019-2024
    Published: 15-Feb-2019        Price: US 3660 Onwards        Pages: 132
    Solid Organ Transplant Immunosuppressant is a class of drugs that suppress or reduce the strength of the body's immune system in solid organ transplant. In the next five years, the global consumption of Solid Organ Transplant Immunosuppressant will maintain more than 6% annual growth rate. At present, Chinese domestic enterprise technology is developing fast, and the Chinese companies mainly supply the domestic market. Due to China lifted organ donation of executed prisoners......
  • Global Zika Virus Testing Market Insights, Forecast to 2025
    Published: 15-Feb-2019        Price: US 4900 Onwards        Pages: 118
    Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten b......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs